Normally associated with advanced cirrhossis, hepatic encephalopathy can present in varying degrees of severity that covers a ...

How has it changed? Studying pathology based on the last three years"I remember the names and symptoms of diseases, but I can't solve situation-based questions."Have you ever felt this way while ...

Hepatic encephalopathy (HE) is a neurologic complication of advanced liver disease, causing impaired functioning, reduced quality of life (QOL), and increased hospitalisation and mortality. This ...

High-dose GLP-1 RA therapy is associated with a reduced risk for hepatic encephalopathy, supporting its use for patients without liver cancer. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may ...

In a groundbreaking population-based study published in Pediatric Research, French researchers have unveiled critical insights into the long-term outcomes of neonates suffering from hypoxic-ischemic ...

Hepatic encephalopathy (HE), a common neurological complication in end-stage cirrhosis, is a complex disorder whose molecular pathogenesis has yet to be fully elucidated. Metabolomics studies provide ...

The American College of Gastroenterology released guidelines for hepatic encephalopathy that focus on diagnostic testing, treatment options, and considerations for inpatient vs outpatient care.

Please provide your email address to receive an email when new articles are posted on . Hepatic encephalopathy can have substantial negative impact on patients, family and health care systems.

Primary biliary cholangitis (PBC) is a chronic cholestatic disorder in which symptoms exert a direct influence on patients’ quality of life. Beyond pruritus and fatigue, patients with PBC are also ...

IgA nephropathy, first described in 1968 by Berger and Hinglais, 1 is the most common form of primary glomerulonephritis. For decades, IgA nephropathy was considered to have a relatively good ...